NovoCure (NVCR) Other Gross PP&E Adjustments (2014 - 2026)

NovoCure's Other Gross PP&E Adjustments history runs 13 years deep, the most recent figure standing at -$45.5 million for Q1 2026.

• In Q1 2026, Other Gross PP&E Adjustments rose 6.26% year-over-year to -$45.5 million; the TTM figure through Mar 2026 stood at -$45.5 million (up 6.26% YoY), while the FY2025 annual figure was $48.3 million, up 2.03% from the prior year.
• Other Gross PP&E Adjustments came in at -$45.5 million for Q1 2026 at NovoCure, down from $48.3 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $48.3 million in Q4 2025 to a low of -$48.5 million in Q1 2025.
• A 5-year average of -$18.2 million and a median of -$26.3 million in 2023 frame the typical range for Other Gross PP&E Adjustments.
• Across the five-year window, Other Gross PP&E Adjustments soared 347.62% in 2023 and slumped 70.85% in 2025, its largest moves.
• NovoCure's Other Gross PP&E Adjustments stood at $2.7 million in 2022, then surged by 347.62% to $12.0 million in 2023, then jumped by 295.99% to $47.4 million in 2024, then grew by 2.03% to $48.3 million in 2025, then slumped by 194.07% to -$45.5 million in 2026.
• According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered -$45.5 million, $48.3 million, and -$48.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison